POSA70 Budget Impact Analysis of Avelumab Plus Best Supportive Care (BSC) vs BSC Alone as First-Line (1L) Maintenance Treatment in Patients With Locally Advanced (LA) or Metastatic Urothelial Carcinoma (mUC) in Taiwan

Autor: Tsai, YC, Lin, AY, Huang, J, Wu, E, Liu, K, Palencia, R, Chang, J, Kearney, M
Zdroj: In Value in Health January 2022 25(1) Supplement:S47-S47
Databáze: ScienceDirect
Externí odkaz: